The review discusses 58 peptides in different clinical phases, indicating a robust pipeline of peptide therapies concentrating on PPIs. For instance, the latest studies have highlighted the efficacy of peptide therapies in managing autoimmune health conditions, with people dealing with fewer Negative effects when compared with traditional therap